Monthly Archives: October 2009

With the issue of data exclusivity for novel biologics re-emerging in the news, I’d like to present two arguments that will be published in the upcoming issue of the Journal of Commercial Biotechnology:

Why data exclusivity is the new patent protection
Peter J Pitts, Center for medicine in the public interest

Follow-on biologic drug competition – No need for new marketing exclusivities
Michael S Wroblewski(a) and Elizabeth A Jex(b)
a) Office of Policy Planning, Federal Trade Commission
b) FTC Office of Policy Planning

I am honored to have been selected for the 2009 Kyoto Prize Journalism Fellowship, offered by Point Loma Nazarene University.

This fellowship will allow me to attend the Kyoto Prize Ceremony, laureate lectures and workshops, and associated functions. The Kyoto Prize is one of the world’s most prestigious awards given to those who have made outstanding lifetime achievements in technology, science, or the arts. This year’s laureates are:

Dr. Isamu Akasaki, Blue LED pioneer

Drs. Peter and Rosemary Grant, Evolutionary Biologists

Pierre Boulez, World-renowned composer, conductor

I am honored to have the opportunity to attend this prestigious event and to learn more about innovation in diverse disciplines.

Courtesy of

Drug Patent Expirations in October 2009

Tradename Applicant Generic Name Patent Number Patent Expiration
BREATHTEK UBT FOR H-PYLORI Otsuka America urea, c-13 4,830,010 Oct 27, 2009
CEDAX Sciele Pharma Inc ceftibuten dihydrate 4,634,697 Oct 1, 2009
COLGATE TOTAL Colgate Palmolive sodium fluoride; triclosan 5,156,835 Oct 20, 2009
COVERA-HS Gd Searle Llc verapamil hydrochloride 5,785,994 Oct 22, 2009
DOXIL Ortho Biotech doxorubicin hydrochloride 5,013,556 Oct 20, 2009
DOXIL Ortho Biotech doxorubicin hydrochloride 5,213,804 Oct 20, 2009
FLOMAX Boehringer Ingelheim tamsulosin hydrochloride 4,703,063 Oct 27, 2009
INVEGA SUSTENNA Johnson And Johnson paliperidone palmitate 5,254,556 Oct 27, 2009
MERETEK UBT KIT (W/ PRANACTIN) Otsuka America urea, c-13 4,830,010 Oct 27, 2009
PERMAX Valeant Pharm Intl pergolide mesylate 5,114,948 Oct 19, 2009

*Drugs may be covered by multiple patents

Courtesy of

This information is also available in an email newsletter: Subscribe to the DrugPatentWatch Patent Expiration Bulletin.